百家乐怎么玩-澳门百家乐官网娱乐城网址_网上百家乐是不是真的_全讯网888 (中国)·官方网站

Greater Bay Biotechnology

 

Greater Bay Biotechnology focuses on developing innovative microneedles device for drug and cell delivery. Our cryomicroneedles (CMNs) is an innovative device which allows effective storage, transportation, and in situ delivery of living cells, biologics and drug. Applications include diabetes treatment, cell and dermatology therapy.

Greater Bay Biotechnology is founded by researchers from City University of Hong Kong and is supported by CityU HK Tech 300 Seed Fund and The Hong Kong Science and Technology Parks Corporation (HKSTP) IDEATION Programme. We received multiple accolades for our innovation.

We work in partnership with pharmaceutical companies to develop innovative, minimally invasive and safe drug and cell delivery solutions. This include delivering insulin using our CMNs as a minimally invasive treatment option for the 130 million diabetes patients in China. We also expand the application of microneedles technology in the delivery of other drug, cosmetic and cell formulations.

 

 

Team members

Mr Ng Chelon Colin* (Master, Dept. of Biomedical Sciences, CityU)
Dr Zheng Mengjia (Postdoc, Dept. of Biomedical Engineering, CityU)
Ms Zhang Yuyue (PhD, Dept. of Biomedical Engineering, CityU)
Ms Zhang Jitian (PhD, Dept. of Biomedical Sciences, CityU)

* Person-in-charge
(Info based on the team's application form)

Achievement(s)
  1. CityU HK Tech 300 Seed Fund (2021)
  2. The Hong Kong Science and Technology Parks Corporation (HKSTP) IDEATION Programme
  3. Second runner-up, Hong Kong Chapter of “Maker in China” SME Innovation and Entrepreneurship Global Contest 2021
  4. Silver Prize, The 7th China International College Students’ “Internet+” Innovation and Entrepreneurship Competition
  5. Second prize, The 4th "Beijing-Hong Kong Youth Innovation and Entrepreneur Cup" Entrepreneurship Competition
  6. Third Prize, 2022 Chengdu "Rongpiao Cup" High-level Talents Innovation and Entrepreneurship Competition (Shuangliu District and Guangdong-Hong Kong-Macao Greater Bay Area Competition)
  7. Third prize, 2021 “創匯香湘" Innovation and Entrepreneurship Competition
  8. Selected to be in the Ministry of Industry and Information Technology (MIIT) First "Light of Innovation" SME technological innovation outstanding achievement list  (the only selected enterprise in Hong Kong, Macao and Taiwan)
  9. Selected to be as The 4th Guangdong-Hong Kong-Macao Greater Bay Area Top 50 Innovative Biotechnology Enterprises

 


联众百家乐官网的玩法技巧和规则| 云博娱乐城,| 百家乐官网统计工具| 2404这个房号 风水| 现场百家乐投注| 百家乐款| 明升备用地址| 百家乐官网作弊手段| 真人游戏| 百家乐官网赌的技巧| 百家乐官网平台哪个有在线支付呢 | 百家乐官网娱乐网代理佣金| 百家乐下注平台| 赌博百家乐规则| 广州太阳城大酒店| 四海资迅| 克拉克百家乐官网的玩法技巧和规则| 至尊百家乐网| 大发888娱乐下载| 百家乐官网足球| 百家乐博牌规例| 娱乐城开户送金| 百家乐官网网页游戏网址| 电子百家乐官网技巧| 威尼斯人娱乐城网络百家乐| 东海县| 金龍百家乐官网的玩法技巧和规则 | 博彩投注| 凤城市| 金沙百家乐官网的玩法技巧和规则 | 六合彩138| 百家乐官网款| 巴特百家乐的玩法技巧和规则| 海南博彩业| 最可信百家乐官网娱乐城| 手机棋牌游戏下载| 澳门百家乐官网有没有假| 百家乐庄闲机率分析| 威尼斯人娱乐城打造| 百家乐官网赌场在线娱乐| 网上百家乐开户送现金|